Datadog Stock Plunges Despite Strong Q2 Beat — Soft Guidance Blamed
Despite beating estimates and lifting full-year outlook, Datadog shares fell sharply on soft Q3 sequential growth guidance.
NOTRELOAD AI
FDA Approves ORZEYFUL: First Medicine to Treat the Root Cause of Narcolepsy Type 1
Twice-daily pill improves wakefulness and reduces symptoms.
Constellation Energy Shares Surge on Strong Q2 Results and Higher Outlook
Constellation Energy seals 920 MW of 15-20 year clean power PPAs, including a major Walmart deal to expand Dresden. Contracts start 2029-2032.
CELH Shares Plunge After Q2 Miss: Core Celsius Brand Falters
CELH shares fell after weak sales, lower profits, and core brand slowdown raised concerns despite growth from Alani Nu and Rockstar.
Oscar Health Beats Expectations With Record Profits and Raises 2026 Outlook
Membership near 3M as medical costs ease and outlook rises.
HubSpot Beats Q2 Estimates but Guidance Miss Sparks Sharp Sell-Off
Despite beating Q2 estimates, HubSpot’s weaker guidance, AI-related challenges, and two analyst downgrades sent shares sharply lower as growth momentum slows.